trending Market Intelligence /marketintelligence/en/news-insights/trending/f7Bv83Awh-C7d0FAqXBjGg2 content esgSubNav
In This List

Braeburn Pharmaceuticals withdraws IPO

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Braeburn Pharmaceuticals withdraws IPO

Braeburn Pharmaceuticals Inc. withdrew plans for an IPO due to uncertainty in the U.S. healthcare industry, Reuters reported.

The Princeton, N.J.-based company was looking to offer 7.7 million shares in the $18 per share to $21 per share range but will consider such a move at a later date.

Apple Tree Partners, a private equity and venture capital firm, is the sole shareholder of Braeburn Pharmaceuticals, which manufactures implants for opioid addiction.